Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.96 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.96 |
| ▸ | FNTA | P49354 | 4/20 | 0.60 |
| ▸ | FNTB | P49356 | 4/20 | 0.60 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28486071 | 1.00 | ALDH1A1 (0.96) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL11404533 | 1.00 | ALDH1A1 (0.96) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL11410939 | 1.00 | ALDH1A1 (0.96) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL806825 | 1.00 | ALDH1A1 (0.96) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL806928 | 1.00 | ALDH1A1 (0.96) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL1301763 | 1.00 | ALDH1A1 (0.96) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL806725 | 1.00 | ALDH1A1 (0.96) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL1301765 | 1.00 | ALDH1A1 (0.96) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL11404530 | 1.00 | ALDH1A1 (0.96) | ALDH1A1ALOX15FNTAFNTBPGGT1B | |
| SCHEMBL806690 | 1.00 | ALDH1A1 (0.96) | ALDH1A1ALOX15FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125730-A1 | A NEW INDUCER FOR METHANOL-FREE PICHIA PASTORIS EXPRESSION SYSTEM | ATATURK UNIVERSITESI REKTORLUGU BILIMSEL ARASTIRMA PROJELERI ( BAP ) KOORDINASYON BIRIMI (TR) | 2026-05-07 | — | — | US | claimed |
| CN-120153986-A | Cowpea thrips intelligent physicochemical induction control system based on deep learning | 三亚中国农业科学院国家南繁研究院 | 2025-06-17 | — | — | CN | claimed |
| WO-2025068206-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2025-04-03 | — | — | WO | claimed |
| US-20250017833-A1 | MALODOR-COUNTERACTING COMPOUNDS, COMPOSITIONS, AND USES THEREOF | INT FLAVORS & FRAGRANCES INC (US) | 2025-01-16 | — | — | US | claimed |
| US-12194020-B2 | Reversing baldness through cannabinoid receptor activation | POSTREL RICHARD (US) | 2025-01-14 | — | — | US | claimed |
| US-12161686-B2 | Natural preservatives and antimicrobial agents, including compositions thereof | UNIGEN, INC. (US) | 2024-12-10 | — | — | US | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| EP-4419070-A1 | MALODOR-COUNTERACTING COMPOUNDS, COMPOSITIONS, AND USES THEREOF | International Flavors & Fragrances Inc. (US) | 2024-08-28 | — | — | EP | claimed |
| CN-118203512-A | Natural mild oil-control anti-dandruff solid shampoo and preparation method thereof | 广州美思生物技术有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-118119372-A | Malodor-counteracting compositions, compositions and uses thereof | 国际香料和香精公司 | 2024-05-31 | — | — | CN | claimed |
| US-5658575-A | OIL IN WATER EMULSION | L'OREAL (FR) | 1997-08-19 | — | — | US | claimed |
| EP-0705593-B1 | Dermatologic or cosmetic composition made up by an oil in water emulsion based on oily globules coated with a lamellar liquid crystal coating | OREAL (FR) | 1996-10-23 | — | — | EP | claimed |
| US-5567729-A | USED TO REDUCE THE LEVEL OF PROTEIN FARNESYLATION IN MAMMALS | Bradfute, David L. (US) | 1996-10-22 | — | — | US | claimed |
| EP-0641557-B1 | Dermatologic or cosmetic composition made up by an oil in water emulsion based on oily globules coated with a lamellar liquid crystal coating | OREAL (FR) | 1996-08-21 | — | — | EP | claimed |
| US-5475029-A | Farnesyl compounds as cholesterol lowering agents | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 1995-12-12 | — | — | US | claimed |
| US-5472699-A | A skin protective mixture comprising an oil absorbing powder, a botanical astringent and a sebum production regulating compound; anti-oil secretion | AVON PRODUCTS, INC. (US) | 1995-12-05 | — | — | US | claimed |
| CN-1108089-A | Cosmetic or skin using composition of emulsion of oil covered with water formed with oil drops and covered with liquid | OREAL (FR) | 1995-09-13 | — | — | CN | claimed |
| EP-0447318-B1 | Composition for the cosmetic and/or pharmaceutical treatment of the surface epidermal layers by topical application on the skin and the relative production process | OREAL (FR) | 1995-05-31 | — | — | EP | claimed |
| US-5415861-A | Skin treatment, astringents and powders | AVON PRODUCTS, INC. (US) | 1995-05-16 | — | — | US | claimed |
| US-4214909-A | SESQUITERPENE ALCOHOLS AND CARBOXYLIC ACID ESTERS THEREOF | KURARAY CO., LTD. (JP) | 1980-07-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125730-A1 | A NEW INDUCER FOR METHANOL-FREE PICHIA PASTORIS EXPRESSION SYSTEM | ERG28, PAOX, ACOX1 | ALDH1A1 977/4885ALOX15 683/4885FNTA 61/4885 |
| US-20250017833-A1 | MALODOR-COUNTERACTING COMPOUNDS, COMPOSITIONS, AND USES THEREOF | MAL2, LPO, SMURF1 | ALDH1A1 235/4885ALOX15 6/4885FNTA 478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.